460
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Iron Deficiency and Blood Donation: Links, Risks and Management

ORCID Icon, , ORCID Icon, &
Pages 775-786 | Received 24 Sep 2022, Accepted 05 Dec 2022, Published online: 10 Dec 2022
 

Abstract

The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties.

Abbreviations

AABB, American Association of Blood Banks; IDA, iron deficiency anemia; IDWA, iron deficiency without anemia; MCH, mean corpuscular (cell) hemoglobin; MCHr, mean cell hemoglobin of reticulocytes; MCV, mean corpuscular (cell) volume; Ret-He, reticulocyte hemoglobin content; RLS, restless leg syndrome; sTfR, soluble transferrin receptors; TIBC, total iron binding capacity; TSAT, transferrin saturation; US, United States of America; WB, whole blood; ZPP, zinc protoporphyrin.

Consent for Publication

All authors approved the submitted text and are accountable for all aspects of this work.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors have nothing to disclose about the current review article.

Additional information

Funding

No funding was available for this manuscript.